The mean CXCL1 in mismatched and matched BMT received AML patients was 87±8.5 pg/mL, 79±12.2 pg/mL and 54.3±7.6 pg/mL, respectively. This evidence concerns the gene CXCL1 and acute myeloid leukemia.